Happy 4th of July! We’re taking the time today to reflect on our history and achievements as a nation, and how we can continue to embody the spirit of independence in all we do. #IndependenceDay
Amicus Therapeutics
Biotechnology Research
Princeton , NJ 42,831 followers
Our passion for making a difference unites us.
About us
We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Amicus is the Latin word for friend. This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way. Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease. That spirit of empathy, compassion, and tenacity permeates our culture and influences all aspects of our approach to advancing cutting-edge technologies. Building on our core beliefs, our mission-focused behaviors help us define and shape our culture; drive performance and innovation; inform development and growth; and attract, energize, and retain the right talent. By championing mission-dedication, innovation, performance, and integrity, we are united by our passion for making a difference and committed to pushing ideas as far and as fast as possible. Our global footprint spans over 20 countries, including our global headquarters in Princeton, NJ and international headquarters in Marlow, UK. Additional international office locations include Australia, Canada, France, Japan, Germany, Italy, The Netherlands, and Spain. More information about Amicus and our career opportunities can be found at www.amicusrx.com.
- Website
-
http://www.amicusrx.com
External link for Amicus Therapeutics
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Princeton , NJ
- Type
- Public Company
- Founded
- 2002
Locations
Employees at Amicus Therapeutics
Updates
-
In honor of #Juneteenth, we celebrate the resilience, strength, and contributions of the African American community. This legacy reminds us of the power of hope in uncertain times. Join us and our LIFTED Employee Resource Group as we honor this day by reflecting on our history and continuing the work toward inclusivity for all.
-
We recognize Pride month by celebrating with the global LGBTQ+ community through the work of our PRISM Employee Resource Group. #AmicusCares #Pride #LGBTQ
-
Amicus is the Latin word for “friend”. This name signifies our collaborative approach to developing technologies and incorporating the patient perspective in every step of drug development. Learn more at http://amicusrx.com #raredisease #AmicusCares
-
At Amicus, our Veterans’ ERG, SERVE, is a pillar of support for our veteran colleagues. On behalf of SERVE and Amicus, we honor and remember the brave men and women who made the ultimate sacrifice for our freedom. #MemorialDay #AmicusCares
-
Our compliance culture is driven by integrity and a commitment to never prioritize short-term profit over sustainable long-term success. Learn more in our 2024 ESG report: bit.ly/4cGt09D #ESG #AmicusCares
-
We were delighted to join many others at the #ECRD2024. We are excited to share our latest work on capturing and elevating patient perspectives in #PompeDisease. As always, it was an honor to work with the Pompe community to bring this together and demonstrate what is important to patients and families. #raredisease #patientadvocacy #patientvoice
-
Over one billion people worldwide live with a #disability or impairment. At Amicus, our Disability & Rare Advancement in the Workplace (DRAW) Employee Resource Group (ERG) helps us understand the importance of digital access and inclusion for all. #GAAD #AmicusCares #DEI
Affiliated pages
Similar pages
Browse jobs
Stock
FOLD
NASDAQ
20 minutes delay
$9.55
-0.53 (-5.258%)
- Open
- 9.62
- Low
- 9.355
- High
- 9.84
Data from Refinitiv
See more info on